Researchers from Tokyo Medical and Dental University evaluated the safety of an anti-VEGF drug, aflibercept, in a cell culture model exposed to human T-cell lymphotropic virus type 1, which is known to cause a number of diseases, including inflammatory diseases of the eye.
The Cardinal Health study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments.
Outcomes achieved with information, osmolarity testing, proven treatments
The study compared 126 IOL injectors of 13 IOL injector systems regarding the manufacturers’ recommended preoperative incision sizes to evaluate the intraoperative incision enlargement and postoperative incision sizes.
The Alteogen Inc. subsidiary company provided an update on its ALT-L9 biosimilar to compete with EYLEA
A comparison of Hoya Vivinex and Alcon AcrySof lenses evaluated the long-term formation of posterior capsular opacification (PCO) and the rate of glistenings that developed.
SBI-100 Ophthalmic Emulsion is a synthetic cannabinoid derivative to treat glaucoma and ocular hypertension.
Data shows the Notal Vision Home OCT device can be used to manage wet age-related macular degeneration (AMD).
The Keralink Trial was the first randomized clinical trial that tested the hypothesis that corneal cross-linking (CXL) might decrease keratoconus progression in children compared with the use of spectacles or contact lenses.
The latest IOLs offer an improvement in stray light performance and enhanced contrast.
Yusuke Oshima, MD, PhD, in a presentation at the 38th Asia-Pacific Academy of Ophthalmology Congress, Kuala Lumpur, Malaysia, discussed the advantages of using a beveled-tip ultra-speed probe for complete vitreous shaving during retinal detachment vitrectomies.
In a presentation at the Asia-Pacific Academy of Ophthalmology Congress in Kuala Lumpur, Malaysia, Kyoko Ohno-Matsui, MD, PhD, noted that changes of scleral curvature and staphyloma edge development may occur in synchronicity.
According to Regeneron, the BLA is supported by two pivotal trials demonstrating non-inferior vision gains to aflibercept injection, with a majority of patients maintaining extended dosing regimens through 48 weeks.
Global Pharma agrees to recall Delsam Pharma’s over-the-counter Artificial Eye Ointment due to potential bacterial contamination.
Analysis of data from the pooled Tenaya and Lucerne studies showed the faricimab achieved greater anatomic improvements compared to aflibercept during the matched-dosing period.
Arun Singh, MD, discusses Retinoblastoma in 2023 and the advancements of tumor chemotherapy from his presentation at the Asia-Pacific Academy of Ophthalmology (APAO) 2023 conference.
Ophthalmologists should be aware of a patient’s prior history
Multiple attendees of this year's EnVision Summit share insights into what makes the EnVision Summit an enjoyable experience and a great place to learn.
The considerations for biosimilars in clinical practice are interesting and remain to be determined, according to George A. Williams, MD.
According to the company, the investigational, novel eye drop candidate was assigned a PDUFA goal date of October 22, 2023.
Ophthalmologists see new therapy as having a major impact on how geographic atrophy is treated.
Multiple attendees of this year's EnVision Summit share insights into their presentations.
Sessions offer training in ophthalmic translational research, problem-based learning
In a presentation at the EnVision Summit 2023 in Puerto Rico, Sumayya Ahmad, MD, pointed out that for patients with lower Schirmer’s scores and corneal staining, PRK may be a good choice. If the dry eye can be treated preoperatively and the eye has no staining, surgeons can consider LASIK.
Surgeon notes there is no good solution for ending use of topical medications
Those attending the Asia-Pacific Academy of Ophthalmology congress In Kuala Lumpur can celebrate the reconvening of the congress after a 2-year hiatus by joining in the “We Are Back” Fundraising Run.
In addition to observation, laser-assisted vitreolysis and pars plana vitrectomy (PPV) are options, all of which deserve careful consideration.
Having the best tools available is of the utmost importance in the operating room (OR).
At the EnVision Summit Ophthalmology in Puerto Rico, Grace Sun, MD, made a presentation titled "Surgical Curriculum for Ophthalmology Residents" to train them to be competent in a broad range of basic and advanced surgical skills.
